Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2007

View Archived Issues

Recent Merck & Co. and Merck Sharp & Dohme patent discloses new antipsychotic agents

Novel therapeutic agents for respiratory disorders described in recent patents

Recent patents disclose novel compounds targeting HCV infection

Liposome encapsulated OGG1 may be useful to promote DNA repair in UV-irradiated skin cells

Roche reports phase I data on R-667 for the treatment of emphysema

VASTox to advance programs targeting symptoms of Parkinson's disease

TAK-390MR demonstrates extended exposure in humans

Clinical trials of new drugs for Crohn's disease and ulcerative colitis

Tolerability and activity of MK-0822 on bone resorption markers in healthy postmenopausal women

Natural blood components inhibit HIV-1 entry by targeting the gp41 fusion peptide

Enrollment completed in phase III trial of CellCept in pemphigus vulgaris

Arete Therapeutics raises additional financing

New trial studies everolimus-eluting self-expanding stent for PAD

Chidamide begins phase I study in China

Suspension of phase III study of Cloretazine in relapsed AML

CoGenesys reports milestones from licensing agreements

AEOL-10150 to be studied in mustard gas-mediated lung injury

AAGP increases recovery rate of cryopreserved stem cells

German sites cleared to begin phase II study of MORAb-003 in ovarian cancer

BioDiem reveals new vaccine strategy for potential influenza pandemic

Genvax immunostimulant elicits cellular immune response in prostate cancer

CE Mark for Taxus Liberte Long stent

Nalmefene licensing agreement enters into force

Multikine increases long-term overall survival in head and neck cancer

Results from phase III trauma trial with PolyHeme

CHF-5407 profiled as a novel M3 antagonist for the treatment of COPD

Snapshots of preclinical antiviral studies

Japanese approval for Glufast in combination with alpha-GI

BioMarin files NDA for Kuvan for PKU

Mircera recommended for approval in E.U.

Lacosamide filed in Europe as adjunctive therapy of epilepsy

Siena Biotech and Roche collaborate in neurodegenerative diseases

Salvacyl/Moapar completes European mutual recognition procedure

Levitra 20 mg tablet approved in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...